Mirion Technologies (NYSE:MIR) Issues Earnings Results

Mirion Technologies (NYSE:MIR) issued its quarterly earnings results on Tuesday. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02, Zacks reports. Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. Mirion Technologies updated its FY 2025 guidance to 0.450-0.500 EPS.

Mirion Technologies Price Performance

Mirion Technologies stock opened at $16.16 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.16 and a quick ratio of 1.55. The business has a 50 day simple moving average of $17.02 and a 200 day simple moving average of $14.03. Mirion Technologies has a one year low of $9.11 and a one year high of $18.81. The company has a market capitalization of $3.75 billion, a PE ratio of -47.51 and a beta of 0.73.

Analysts Set New Price Targets

MIR has been the topic of several recent research reports. The Goldman Sachs Group lifted their price objective on shares of Mirion Technologies from $16.00 to $21.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Citigroup increased their target price on shares of Mirion Technologies from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, December 4th. Robert W. Baird assumed coverage on shares of Mirion Technologies in a research note on Thursday, December 19th. They issued an “outperform” rating and a $22.00 target price on the stock. Finally, Baird R W upgraded shares of Mirion Technologies to a “strong-buy” rating in a research note on Thursday, December 19th. Three equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $19.25.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.